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Background: Hypertension is a common non-communicable illness that can occur either alone or in combination 
with diabetes and other diseases. Diabetic hypertensive patients are more vulnerable to cardiovascular and renal 
complications compared to non-diabetic hypertensive patients. Target blood pressures in these two patient 
populations are different; nevertheless, optimal blood pressure control is paramount in both groups. 
Objective: To evaluate the management of hypertension among diabetic and non-diabetic outpatients at the medical 
outpatient clinic in Kenyatta National Hospital, Nairobi, Kenya. 
Methodology: A tertiary hospital based cross-sectional study was carried out at the medical outpatient clinic in 
Kenyatta National Hospital. This study comprised of two study groups: 48 diabetic hypertensive patients and 48 non-
diabetic hypertensive patients. Face to face interviews were conducted and additional data was extracted from the 
patient’s file. The main outcomes of interests were the BP readings that formed the dependent variable and the 
covariates or factors that influenced BP control that formed the independent variables in both the two arms of study. 
Data was analyzed using SPSS version 19.0 software. The level of significance was determined using Pearson chi 
square set at 0.05 and p values < 0.05 were considered to be statistically significant. 
Results: Of the 96 patients enrolled, the male to female ratio was 1:2, the mean age was 57 years (+11.1) and the 
mean duration of hypertension was 7.7 years (+6.3). Overall, 70% of the entire study population had inadequate 
blood pressure control. Among the diabetic patients, 75% had inadequate blood pressure control compared to 65% of 
the non-diabetic patients. Three quarters of the diabetic patients were on > 2 antihypertensive drugs compared to 
98% of the non-diabetic patients.  
Conclusion: Control of hypertension in both diabetic and non-diabetic hypertensive patients is poor. We suggest that 
patient involvement, patient education and continuous counseling on hypertension are essential in the overall 
management of hypertension.  
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1. Introduction 
Globally, there are about 972 million adults with 
hypertension and this figure is expected to rise to about 
1.56 billion by the year 2025. Hypertension is 
characterized by persistently elevated arterial blood 
pressure (BP) and is one of the most significant risk 
factor for cardiovascular disease (CVD), stroke and 
renal failure (Rosendorff et al, 2007). These 
complications are more common in patients with both 
diabetes and hypertension as they have a 3-fold 
increased risk of CVD and a 2-fold increase risk of renal 
disease compared to patients without diabetes (Torre et 
al, 2006). In Kenya, the proportion of patient with 
poorly controlled BP is still a big challenge in both 
diabetic and non-diabetic patients (Achieng, 2008; 
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Mwendwa, 2001; Vaghela, 2001). Despite the presence 
of current treatment guidelines for hypertension, it still 
remains poorly controlled (Wanjiru, 2011; Wafula, 
2010). Hypertension is, therefore, still a growing 
problem within our set up and also accounts for the 
high number of patient flow at our outpatient clinics 
Reasons for poor blood pressure control have been 
extensively studied and these factors include: low 
knowledge on hypertension amongst patients, poor 
adherence to drugs and lifestyle modification strategies, 
economical constraints, psychosocial stress, limited 
access to health care services, amongst others. In 
addition, physicians can also contribute to inadequate 
BP control due to failure to prescribe lifestyle 
modification strategies, failure to modify or intensify 
therapy based on patient’s response, suboptimal dosing 
of drugs, inappropriate drug selections or drug 
combinations and poor patient follow up.   
The purpose of this study is, therefore, to evaluate the 
adequacy in BP control, find out patient-related factors 
that could influence BP control and describe the 
prescribing patterns of antihypertensive drug therapy 
among diabetic and non-diabetic patients. 
2. Methodology 
2.1 Study Design  
A tertiary hospital based cross-sectional study was 
carried out at the medical outpatient clinic in Kenyatta 
National Hospital, Nairobi, Kenya. The study comprised 
of two study arms: 48 adult diabetic hypertensive 
patients and 48 adult non-diabetic hypertensive 
patients, all of whom, had been on antihypertensive 
drugs for at least 12 months. 
2.2 Sampling and Data Collection Technique 
The sample size was determined using the formula for 
comparing two independent proportions which 
assumes that the numbers of participants to be enrolled 
into each arm of the study to be equal (Daniel, 1999). 
This formula was selected because the study involved 
comparing variables between two study groups. 
Convenience sampling method was used to select the 
patients to be interviewed. This method of sampling 
assisted in easy identification of patients who fitted the 
study’s inclusion criteria and also minimized 
interference with patient flow in the clinic. Only 
patients who gave consent to the study were 
interviewed. Information obtained from the interviews 
was entered into a predesigned questionnaire; and data 
on previous BP readings, prescribed drugs and other 
comorbidities were retrieved from the same patient’s 
file.   
2.3 Study Variables 
The main outcomes of interests were the BP readings 
that formed the dependent variable and the covariates 
or factors that influenced BP control that formed the 
independent variables. Some of these factors included: 
knowledge on hypertension, compliance to drug 
therapy, adherence to lifestyle modification strategies, 
exposure to any of the common psychosocial stressors 
and the prescribed antihypertensive drug regimen. 
Possible confounders identified in this study included 
older age, sex, obesity, duration of illness, and the 
presence of other comorbidities.     
2.4 Data Processing and Analysis 
All the raw data was coded and directly entered by 
either the biostatistician or the principal investigator 
onto a pre-formed excel database (version 2007). On 
completion, data was exported and analyzed using SPSS 
version 19.0 software. Analysis involved use of 
descriptive and inferential statistics. Cross tabulations 
were done to compare data between the two arms of 
study. For the purpose of analysis, a patient was 
considered to have adequate BP control if 2 out of the 3 
most recent BP readings (at most 6 months apart) taken 
within the last 12 months were as per the 
recommendations given by the Seventh Report of the 
Joint National Committee (JNC7) on the Prevention, 
Detection, Evaluation and Treatment of High Blood 
Pressure (Chobanian et al, 2003). The level of 
significance was determined using the Pearson chi 
square set at 0.05 and p values < 0.05 were considered 
to be statistically significant. 
2.5 Ethical Considerations 
Research was conducted after getting approval from the 
Kenyatta National Hospital/University of Nairobi Ethics 
and Research Committee (KNH/UON-ERC, Ref. No.; 
P100/03/2013).  Only patients who met the inclusion 
criteria and gave their consent were enrolled into the 
study. Participants’ identities were safeguarded by use 
serial numbers and the principal investigator was able 
to address any concerns the participant had with regard 
to their illness and its management. 
3.  Results  
3.1 Socio-demographic Data 
Two thirds of the entire study population was female 
(66.7%) while the rest were males. The mean age of the 
study population was 57 years (+11.1) and the mean 
duration of hypertension was 7.7 years (+6.3).The 
baseline characteristics of this study are described in 
Table 1. 
3.2 Patient-Related Factors that could Influence 
Blood Pressure Control 
This study looked into the following factors: knowledge 
on hypertension, commitment to therapy, lifestyle 
modification strategies and psychosocial stressors as 
indicated in Table 2. 
Most of the patients (90.6%) in the entire study 
populations were not aware of their ideal BP target. 
Almost three quarters of them had been informed of the 
complications that could arise if their blood pressure 
was not controlled and about half of them were aware 
that they would be taking their BP medications for life. 
The complications due to uncontrolled hypertension 
that were looked at were damage to eyes, brain, kidneys 
and heart. More of the non-diabetic patients (43.8%) 
were aware of damage uncontrolled had on the brain as 
compared to the diabetic patients (39.6%; p = 0.048).  
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Table 1: Socio-demographic characteristics 
Socio-demographics Diabetic group Non-diabetic group Total P-value 
 






Male 18 (37.5%) 14 (29.2%) 32 (33.3%) 0.516 






21-40 4 (8.4%) 3 (3.1%) 7 (7.3%) 0.798 
41-60 25 (52%) 29 (60.4%) 53 (55.2%) 
 






Single 6 (12.5%) 4 (8.3%) 10 (10.4%) 0.531 
Married 38 (79.2%) 42 (87.5%) 80 (83.3%) 
 






Informal 8 (16.7%) 6 (12.5%) 14 (14.6%) 0.757 
Primary 19 (39.6%) 16 (33.3%) 35 (36.5%) 
 
Secondary 17 (35.4%) 22 (45.8%) 39 (40.6%) 
 






Self-employed 13 (27.1%) 15 (31.3%) 28 (22.9%) 0.134 
Employed 8 (16.7%) 14 (29.2%) 22 (22.9%) 
 
Unemployed 19 (39.6%) 9 (19.8%) 28 (29.2%) 
 
Retired 8 (16.7%) 10 (20.8%) 18 (18.8%) 
 
Duration of hypertension (years) 7.5(+5.3) 7.9(+7.2) 7.7(+6.3) 0.697 
Mean number of years on BP 
medications 
7.3(+5.2) 7.8(+7.2) 7.6(+6.3) 0.568 









5   (10.4%) 
 
1   (2.1%) 
18 (37.5%) 
20 (41.7%) 












The main reasons given by the patients for being able to 
have a constant supply of their medications and 
sometimes missing to take some of their drug doses 
were lack of funds and forgetfulness. The most 
commonly experienced psychosocial stressors were 
family problems and financial constraints. 
3.3 Prescribing Patterns of Antihypertensive 
Drugs  
Antihypertensive Drug Classes 
The most commonly prescribed antihypertensive drug 
class was the Angiotensin Converting Enzyme Inhibitors 
(ACEIs) and Angiotensin Receptor Blockers (ARBs), 
while the least commonly prescribed were the loop 
diuretics and vasodilators as shown in Table 3.  
Thiazide diuretics (TD) were more commonly 
prescribed among the non-diabetic patients (77%) as 
compared to the diabetic patients (48%; p = 0.006). 
About 60% of the non-diabetic patients were taking 
more than two antihypertensive drugs compared to 
41.7% of the diabetic patients and this difference was 
significant (p = 0.01). The most commonly prescribed 
antihypertensive combination was ACEIs/ARBs + 
Calcium Channel Blockers (CCBs) + Thiazide Diuretics. 
Adequacy in Blood Pressure Control 
Thirty six (75%) of the diabetic patients were found to 
have inadequate BP control compared to 31 (65%) of 
the non-diabetic patients. Associations of various 
independent variables with inadequate BP control are 
shown on Table 4 and 5. A majority of the patients with 
inadequate BP control were above 51 years. Twenty five 
(69.4%) of the diabetic female patients had inadequate 
BP control; compared to 11 (30.5%) of the diabetic 
male patients. This results were comparable to the non-
diabetic patients with 21 (67.7%) of their female 
patients having inadequate BP control compared to 10 
(32.3%) of their male patients (Table 4).   
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Table 2: Patient –related factors that could influence blood pressure control 





n = 48 n = 48 
 
Patient knowledge 
   
Unaware of Ideal BP target 43 (90%) 44 (92%) 0.73 
Unaware of duration of drug therapy 26 (54.2%) 26 (54.2%) 1.0 
Unaware of complications of hypertension 11 (22.9%) 19 (39.6%) 0.078 
Commitment to therapy 
   
Unable to have constant drug supply 14 (29.2%) 19 (39.6%) 0.283 
Misses some BP drug doses 25 (52.1%) 35 (72.9%) 0.035 
Unable to keep clinic appointments 5 (10.4%) 4 (8.3%) 0.726 
Lifestyle modifications strategies 
   
Takes salty food 23 (47.9%) 23 (47.9%) 0.119 
Smokes tobacco 0 (0%) 0 (0%) 1.0 
Eats fatty meals 25 (52.1%) 27 (56.3%) 0.915 
Takes alcohol 2 (4.2%) 0 (0%) 0.192 
Does not eat fruits and vegetables 1 (2.1%) 0 (0%) 0.603 
Does not exercise regularly 10 (20.8%) 7 (14.6%) 0.647 
Psychosocial stressors 
   
Experienced at least one stressor (work-related, 
family or financial) 
39 (81.3%) 38 (79.2%) 0.797 
 
Table 3: Prescribed classes of antihypertensive drugs 
Drug Class Diabetic group Non-diabetic group Total P-value 
 n = 48 n = 48 n = 96  
ACEI/ARB 46 (96%) 41 (85%) 87 (90.6%) 0.159 
TD 23 (48%) 37 (77%) 60 (62.5%) 0.006 
CCB 25 (52%) 34 (70.8%) 59 (61.5%) 0.093 
BB 12 (25%) 18 (38%) 30 (31.3%) 0.275 
LD 2 (4%) 2 (4%) 2 (2.1%) 1.0 
VD 0 (0%) 1 (2.1%) 1 (1%) 1.0 
ACEI-Angiotensin Converting Enzyme Inhibitor, ARB-Angiotensin Receptor Blocker, BB-Beta Blocker, CCB-Calcium 
Channel Blocker, TD-Thiazide Diuretic, LD-Loop Diuretic, VD-Vasodilator 
 
Of the patients found with inadequate BP control, 9 
(25%) of the diabetic patients were unaware of the 
complications brought about by uncontrolled BP 
compared to 14 (45.2%) of the non-diabetic patients 
(Table 5); whereas 15 (41.7%) of the diabetic patients 
were taking more than 2 antihypertensive drugs 
compared to 22 (71%) of the non-diabetic patients 
(p=0.016). 
4. Discussion 
Inadequate BP control was found to be more prevalent 
among the diabetic patients (75%) compared to the 
non-diabetic patients (65%; p=0.374). In another 
similar study done in the United States of America 
(USA), 73% of the diabetic patients were found to have 
inadequate BP control compared to 66% of the non-
diabetic patients (p=0.04). However, this other study 
had a larger sample size of 800 male patients (274 - 
diabetic group vs. 526 - non-diabetic group) as 
compared to ours, which also included both sexes.  In 
addition, BP targets used in the two studies were 
different, specifically that for the diabetic group 
(Belorwitz et al, 2003).  
A majority (90.6%) of the entire study population was 
found to be unaware of their ideal BP target yet they 
had been hypertensive for a long period of time and 
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Table 4: Association between socio-demographic data and inadequate BP control 
Socio-demographics  
Diabetic patients with 
Inadequate BP control 
Non-diabetic patients with 
Inadequate BP control 
P-value 
 
n = 36 n = 31 
 
Sex 
   
Male 11 (30.5%) 10 (32.3%) 1.0 
Female 25 (69.4%) 21 (67.7%) 
 
 Age 
   
21-40 1   (2.8%) 1   (3.2%) 0.497 
41-60 20 (55.6%) 21 (67.7%) 
 
>61 15 (41.7%) 9   (29%) 
 
Marital Status 
   
Single 3   (8.3%) 3   (8.3%) 0.674 
Married 30 (83.3%) 27 (87.1%) 
 
Widowed 3   (8.3%) 1   (3.2%) 
 
Education level 
   
Informal 7   (19.4%) 3   (9.7%) 0.7 
Primary 14 (38.9%) 12 (38.8%) 
 
Secondary 13 (36.1%) 14 (45.2%) 
 
Tertiary 2   (5.6%) 2   (6.5%) 
 
Occupation 
   
Self employed 11 (30.6%) 10 (32.3%) 0.168 
Employed 6   (16.7%) 10 (32.3%) 
 
Unemployed 14 (38.9%) 5   (16.1%) 
 
Retired 5   (16.1%) 6   (19.4%) 
 
 
Table 5: Association between patient-related factors and inadequate BP control 
Patient-related factors 
Diabetic patients with 
inadequate BP control 
Non-diabetic patients with 
inadequate BP control 
P-value 
 
n = 36 n = 31 
 
Patient knowledge 
   
Unaware of Ideal BP target 34 (94.4%) 27 (87.1%) 0.404 
Unaware of duration of BP drugs 22 (61.1%) 22 (71%) 0.4 
Unaware of complications of 
hypertension 
9   (25%) 14 (45.2%) 0.122 
Commitment to therapy 
   
Unable to maintain drug supply 12 (33.3%) 14 (45.2%) 0.451 
Misses some BP drug doses 19 (52.8%) 23 (74.2%) 0.082 
Unable to keep clinic appointments 4   (11.1%) 3   (9.7%) 1 
Lifestyle modifications strategies 
   
Takes salty food 17 (47.2%) 15 (48.4%) 0.8 
Smokes tobacco 0   (0%) 0   (0%) - 
Eats fatty meals 17 (42.7%) 16 (51.6%) 0.828 
Takes alcohol 1   (2.8%) 0   (0%) 1 
Does not eat fresh fruits and vegetables 0   (0%) 0   (0%) - 
Does not exercise regularly 3   (8.3%) 3   (9.7%) 1 
Psychosocial stressors 
   
Work-related problems 8   (22.2%) 7   (22.6%) 1 
Family problems 24 (66.7%) 22 (71%) 0.795 
Financial constraints 23 (63.9%) 18 (58.1%) 0.802 
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A study done in the USA found that only 24% of their 
hypertensive patients were unaware of their ideal BP 
target (Mark et al, 2003). It is unclear why there is this 
gap, perhaps may be due to differences in 
industrialization. Studies have shown that patients who 
were more informed about hypertension tended to have 
better BP control (Johnson and Singh, 2005; Sweileh et 
al, 2010).   
A significant number of our patients reported to be 
adherent to most of the lifestyle modification therapies, 
yet most of them still had inadequate BP. This suggests 
that the use of medication and adherence to lifestyle 
modification strategies may not be the only players in 
optimizing BP control. Nevertheless, further evaluation 
on patients understanding on lifestyle modification 
strategies is required to determine how exactly they try 
to achieve them. For instance, what do they consider to 
be a fatty meal or salty food, what form of exercises do 
they do and how often do they do them. Such an 
evaluation will shed light on whether patients are 
carrying out these lifestyle changes in the correct 
manner, the challenges they face and the impact it has 
on their overall management.    
Our study revelead that most of the prescribing 
patterns for the antihypertensive drug were generally 
consistent with the recommended international 
treatment guidelines on hypertension; nevertheless, a 
large proportion of our patients still had inadequate BP 
control. Even though most of our patients were taking > 
2 antihypertensive drugs, with a majority of them being 
non-diabetic patients (79.2%; p=0.01), BP was still 
poorly managed. This could perhaps be attributed to 
poor patient monitoring, follow up and failure to 
intensify drug therapy whenever required.   
ACEIs/ARBs were the most commonly prescribed 
antihypertensive drugs as found in other similar studies 
(Dhanaraj et al, 2012; Neal et al, 2000; Pahor et al, 
2000). The use of ACEI/ARBs among the diabetic 
patients has been shown to be renal protective and 
their use has also been associated with a significant 
reduction in strokes and CV events (HOPE study,2000; 
PROGRESS collaborative group, 2001; ALLHAT study, 
2002). In addition, ACEI/ARBs are the prefered first-
line drugs for a diabetic patients presenting with 
hypertension (Chobanian et al, 2003).  A study done in 
Nyanza, Kenya also showed that ACEI/ARBs to be the 
most frequently prescribed antihypertensive among 
diabetic patients (Wafula, 2010). 
Thiazide diuretics were more frequently prescribed 
among the non-diabetic patients compared to the 
diabetic patients (p=0.006). Thiazide diuretics are the 
recommended first-line BP drugs for hypertensive 
patients without other compelling indications and have 
been shown to be beneficial especially among the black 
Africans (ALLHAT SG study, 2002).  
Study Limitations 
This study was prone to information bias as it relied on 
the direct responses given by the respondent during the 
patient interviews. This was reduced by adequately 
training the research assistants on how to approach and 
interview the patients. Missing patient files and poor 
recording practices also made it difficult to retrieve all 
the data required for the study. In addition, due to 
varying booking schedules for clinic appointments, 
information on previous BP readings and drugs 
prescribed were recorded at different time intervals 
ranging from every 3, 6 to 12 months. We did not, 
however, seek to find out if these patients sought 
treatment from other health facilities and such 
information would have been important for this study. 
5. Conclusion 
The proportion of patients with inadequate BP control 
still remains high and this challenge is present in both 
the diabetic and non-diabetic patients. Inadequate BP 
control was largely associated with the negative 
influence of patient-related factors. We, therefore, 
conclude that management of hypertension still poses a 
great challenge in both the diabetic and non-diabetic 
patients and studies aimed at addressing patient-
related factors need to be done.  
Health workers attending to hypertensive patients 
should be encouraged to educate and counsel patients 
on hypertension with the hope that this will improve 
patient compliance and consequently better BP control. 
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